Pyxis Oncology, Inc.

NASDAQ:PYXS

Biotechnology

Healthcare
$1.41 +5.53%

+$0.11 today

Market cap
$168.65M
Beta
1.43
P/E (TTM)
-1.6
EPS (TTM)
-$1.29
52W Low $0.97High $5.55

Volume 0.75M

Average 0.50M

Balance Sheet

Inspect the capital base behind the business.

Assets

$91.52M

FY 2025 · Annual

-41.8% YoY

Liabilities

$38.11M

FY 2025 · Annual

+4.6% YoY

Equity

$53.41M

FY 2025 · Annual

-55.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents274.74M179.29M9.66M19.47M15.42M
Short-term Investments00109.63M107.46M51.44M
Net Receivables0598K21K0700K
Inventory00000
Other Current Assets1.56M5.41M4.27M4.75M4.55M
Total Current Assets278.67M186.61M124.6M132.44M72.11M
Property, Plant & Equipment (Net)1.24M24.77M24.81M22.14M19.42M
Goodwill00000
Intangible Assets0024.31M2.6M0
Long-term Investments00000
Tax Assets00000
Other Non-current Assets109K0000
Total Non-current Assets1.35M24.77M49.12M24.74M19.42M
Total Assets280.02M211.38M173.73M157.18M91.52M
Account Payables11.95M7.1M3.9M4.86M10.89M
Short-term Debt00000
Tax Payables00000
Deferred Revenue007.66M00
Other Current Liabilities3.23M5.33M5.58M4.63M3.75M
Total Current Liabilities18.71M31.63M25.76M17.68M21.13M
Long-term Debt00000
Deferred Tax Liabilities002.16M00
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities018.92M22.26M18.75M16.98M
Total Liabilities18.71M50.56M48.02M36.43M38.11M
Common Stock32K34K45K60K63K
Retained Earnings(91.72M)(212.44M)(286.23M)(363.56M)(443.18M)
Accumulated OCI0063K170K53K
Other Stockholders Equity00000
Minority Interest00000
Total Equity261.31M160.82M125.7M120.75M53.41M
Total Debt165K18.92M21.33M20.2M18.67M
Net Debt(274.57M)(160.37M)11.67M727K3.25M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$7.2M
Short-term Investments$35.3M
Other Current$3.1M
Total Current Assets$45.6M
PP&E (Net)$18.7M
Other Non-current-$1
Total Non-current Assets$18.7M
Total Assets$64.3M

Analysis

Selected assets total $64.3M for Latest. The largest visible component is Short-term Investments at $35.3M, about 54.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
4Statement of changes in beneficial ownershipNov 6, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
SC 13G/ASC 13G/A filingNov 3, 2026

How much cash does PYXS have?

Pyxis Oncology, Inc. (PYXS) reported $15.42M in cash and equivalents in fiscal 2025.

How much debt does PYXS carry?

Pyxis Oncology, Inc. (PYXS) reported $18.67M of total debt, with net debt of $3.25M.